<i>MET</i> amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy - Concepedia

Concepedia

Publication | Open Access

<i>MET</i> amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy

DOI Full Paper Access

58

Citations

28

References

2013

Year

Xin An, Fang Wang, Qiong Shao, Feng‐Hua Wang, Zhi‐Qiang Wang, Chen Cui, Cong Li, Hui Luo, Dongsheng Zhang, Rui‐Hua Xu,

Abstract

In patients with recurrent=metastatic gastric cancer,MET amplification and strong protein expression are not rare and appear to be significantly associated with unfavorable clinical outcomes.

References

	Year	Citations

Page 1